Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, presents updated ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Chiadi E. Ndumele, ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Pam Taub, MD, FACC ...
In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and recent clinical insights.
Please provide your email address to receive an email when new articles are posted on . The Heart in Diabetes conference will host its eighth annual meeting June 7-9 in Philadelphia. The meeting will ...
Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...
In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty ...
GREENWICH, Conn.--(BUSINESS WIRE)--Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced that the Japanese Patent Office has issued Japanese Patent No. 7474463 ...
There we go. I'll be making forward-looking statements for the course of the day. So as I noted, Mineralys is focused on how do we target aldosterone in cardiorenal metabolic disorders. We do that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback